is compounded semaglutide being discontinued (GLP-1) Quit a GLP-1? Plan to

[Google Scholar] 30.Drucker D.J

In a rat model of neurodegeneration, GLP-1 and exendin-4 ameliorated neurodegeneration by reducing ibotenic acid-induced depletion of cholinergic cell bodies, as demonstrated by preservation of choline acetyltransferase immunoreactivity in basal forebrain cholinergic neurons [826]

The pilot clinical data is consistent with the mechanism

Tirzepatide, a dual GIP/GLP-1 receptor agonist, has shown even greater efficacy in some studies, with weight reductions of approximately 20% in the SURMOUNT-1 trial

The Science: GLP-1 vs

With minimal to no oversight or instruction, there is a meaningful risk of problems. Microdosing Ozempic may not work for everyone All the health and weight-loss benefits of these drugs are based on research using standard doses